Pangenomic Health Inc.
NARA
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.57M | -2.72M | -1.58M | -2.20M | -8.70M |
| Total Depreciation and Amortization | 8.40K | 9.20K | 9.20K | 9.10K | 9.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.75M | 1.75M | 140.70K | 157.50K | 6.47M |
| Change in Net Operating Assets | 539.90K | 599.80K | 836.00K | 875.80K | 1.04M |
| Cash from Operations | -271.40K | -367.60K | -596.90K | -1.16M | -1.18M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | -2.30K | -2.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -34.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | 0.00 | -2.30K | -36.30K |
| Total Debt Issued | 385.00K | 511.40K | 814.40K | 964.40K | -337.10K |
| Total Debt Repaid | 110.90K | 110.90K | 110.90K | 0.00 | -110.90K |
| Issuance of Common Stock | -- | -- | 900.00 | 639.40K | 2.07M |
| Repurchase of Common Stock | -107.70K | -108.60K | -108.60K | -108.60K | -900.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.70K | -800.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 283.90K | 378.10K | 605.50K | 1.11M | 1.20M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.50K | 10.50K | 8.70K | -56.20K | -11.70K |